國立虎尾科技大學 |

Chagas Disease = A Clinical Approach /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Chagas Disease/ edited by Jaime Marcelo Altcheh, Hector Freilij.
其他題名:	A Clinical Approach /
其他作者:	Altcheh, Jaime Marcelo.
面頁冊數:	XII, 356 p. 48 illus., 34 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Molecular biology. -
電子資源:	https://doi.org/10.1007/978-3-030-00054-7
ISBN:	9783030000547

Chagas Disease = A Clinical Approach /
Chagas DiseaseA Clinical Approach /[electronic resource] :edited by Jaime Marcelo Altcheh, Hector Freilij. - 1st ed. 2019. - XII, 356 p. 48 illus., 34 illus. in color.online resource. - Birkhäuser Advances in Infectious Diseases,2504-3811. - Birkhäuser Advances in Infectious Diseases,.

Overview -- Chapter 1: Chagas disease: past, present and future -- The agent -- Chapter 2: Trypanosoma cruzi Journey from the Insect Vector to the Host Cell -- Chapter 3: A panoramic view of the immune response to Trypanosoma cruzi infection -- Epidemiology -- Chapter 4: Epidemiology of Chagas Disease -- Chapter 5: Chagas Disease in Europe -- Chapter 6: Chagas Disease in the United States (USA) -- Diagnosis -- Chapter 7: Diagnosis of Chagas disease -- Clinical aspects -- Chapter 8: Acute vector-borne Chagas disease -- Chapter 9: Congenital Chagas Disease -- Chapter 10: Chronic Trypanosoma cruzi Infection: Decision Making in the Midst of Uncertainty -- Chapter 11: Orally-Transmitted Chagas Disease: a Neglected Foodborne Infection -- Chapter 12: Gastrointestinal Chagas Disease -- Chapter 13: Chagas in immunosuppressed patients -- Treatment -- Chapter 14: CLINICAL PHARMACOLOGY OF DRUGS FOR THE TREATMENT OF CHAGAS DISEASE -- Chapter 15: In vivo Drug Testing for Experimental Trypanosoma cruzi Infection -- Chapter 16: Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities.

Chagas disease is a potentially life threatening condition that was historically mainly endemic to Latin America. Over the last decade, however, the disease has spread to and is increasingly prevalent in other continents such as North America and Europe, with an estimated 7 million people infected worldwide. It is primarily transmitted by insect vectors that carry the parasite Trypanosoma cruzi, the disease agent. In areas where there is vector control and in non-endemic countries, it is mainly transmitted via congenital infection. Cardiac and gastrointestinal complications are common in untreated individuals.This book offers a comprehensive overview of Chagas disease, including its vectorial and congenital transmission, and molecular diagnosis, which is essential for screening, and developing and providing timely, effective anti-trypanosomal treatment. Written by experts working with infected patients on a daily basis, it discusses the pathogenesis of congenital, cardiac, gastrointestinal and oral Chagas disease, as well as its treatment and the pharmacological aspects of drug development in this area. The chapter, ‘Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities’ is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

ISBN: 9783030000547

Standard No.: 10.1007/978-3-030-00054-7doiSubjects--Topical Terms:

583443
Molecular biology.

LC Class. No.: QH506

Dewey Class. No.: 611.01816

Chagas Disease = A Clinical Approach /
LDR:03841nam a22004095i 4500 001 1005529
003 DE-He213
005 20200701071335.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030000547 $9 978-3-030-00054-7
024 7 $a 10.1007/978-3-030-00054-7 $2 doi
035 $a 978-3-030-00054-7
050 4 $a QH506
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 611.01816 $2 23
245 1 0 $a Chagas Disease $h [electronic resource] : $b A Clinical Approach / $c edited by Jaime Marcelo Altcheh, Hector Freilij.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XII, 356 p. 48 illus., 34 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Birkhäuser Advances in Infectious Diseases, $x 2504-3811
505 0 $a Overview -- Chapter 1: Chagas disease: past, present and future -- The agent -- Chapter 2: Trypanosoma cruzi Journey from the Insect Vector to the Host Cell -- Chapter 3: A panoramic view of the immune response to Trypanosoma cruzi infection -- Epidemiology -- Chapter 4: Epidemiology of Chagas Disease -- Chapter 5: Chagas Disease in Europe -- Chapter 6: Chagas Disease in the United States (USA) -- Diagnosis -- Chapter 7: Diagnosis of Chagas disease -- Clinical aspects -- Chapter 8: Acute vector-borne Chagas disease -- Chapter 9: Congenital Chagas Disease -- Chapter 10: Chronic Trypanosoma cruzi Infection: Decision Making in the Midst of Uncertainty -- Chapter 11: Orally-Transmitted Chagas Disease: a Neglected Foodborne Infection -- Chapter 12: Gastrointestinal Chagas Disease -- Chapter 13: Chagas in immunosuppressed patients -- Treatment -- Chapter 14: CLINICAL PHARMACOLOGY OF DRUGS FOR THE TREATMENT OF CHAGAS DISEASE -- Chapter 15: In vivo Drug Testing for Experimental Trypanosoma cruzi Infection -- Chapter 16: Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities.
520 $a Chagas disease is a potentially life threatening condition that was historically mainly endemic to Latin America. Over the last decade, however, the disease has spread to and is increasingly prevalent in other continents such as North America and Europe, with an estimated 7 million people infected worldwide. It is primarily transmitted by insect vectors that carry the parasite Trypanosoma cruzi, the disease agent. In areas where there is vector control and in non-endemic countries, it is mainly transmitted via congenital infection. Cardiac and gastrointestinal complications are common in untreated individuals.This book offers a comprehensive overview of Chagas disease, including its vectorial and congenital transmission, and molecular diagnosis, which is essential for screening, and developing and providing timely, effective anti-trypanosomal treatment. Written by experts working with infected patients on a daily basis, it discusses the pathogenesis of congenital, cardiac, gastrointestinal and oral Chagas disease, as well as its treatment and the pharmacological aspects of drug development in this area. The chapter, ‘Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities’ is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
650 0 $a Molecular biology. $3 583443
650 0 $a Parasitology. $3 669054
650 0 $a Infectious diseases. $3 1102043
650 1 4 $a Molecular Medicine. $3 668353
650 2 4 $a Infectious Diseases. $3 668393
700 1 $a Altcheh, Jaime Marcelo. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298988
700 1 $a Freilij, Hector. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298989
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030000530
776 0 8 $i Printed edition: $z 9783030000554
830 0 $a Birkhäuser Advances in Infectious Diseases, $x 2504-3811 $3 1271258
856 4 0 $u https://doi.org/10.1007/978-3-030-00054-7
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)